CVR number 14605185K
Industry 21.2000 Manufacture of pharmaceutical preparations

SERA-SCANDIA A/S - Group

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...
Bankruptcy Risk 
2015
N/A
2016
2017/3
2017
2018/3
2018
2018/12
2019
2019/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 1.0% 0.6% 0.6% 29.3%  
Credit score (0-100)  0 89 97 98 2  
Credit rating  N/A A AA AA C  
Credit limit (kDKK)  0.0 4,192.8 8,834.7 10,053.1 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2015
N/A
2016
2017/3
2017
2018/3
2018
2018/12
2019
2019/12
Net sales  0 257,406 283,361 285,502 0  
Gross profit  0.0 57,277 58,978 48,877 0.0  
EBITDA  0.0 39,355 37,960 29,110 0.0  
EBIT  0.0 32,997 32,696 21,142 0.0  
Pre-tax profit (PTP)  0.0 18,077.0 33,905.0 20,059.0 0.0  
Net earnings  0.0 8,044.0 23,358.0 13,479.0 0.0  
Pre-tax profit without non-rec. items  0.0 18,077 33,905 20,059 0.0  
 
See the entire income statement

Balance sheet (kDKK) 
2015
N/A
2016
2017/3
2017
2018/3
2018
2018/12
2019
2019/12
Tangible assets total  0.0 44,043 49,474 53,667 0.0  
Shareholders equity total  0.0 39,870 63,227 76,706 0.0  
Interest-bearing liabilities  0.0 105,382 144,628 137,933 0.0  
Balance sheet total (assets)  0.0 222,667 271,051 287,680 0.0  
Net Debt  0.0 104,199 136,961 123,195 0.0  
 
See the entire balance sheet

Volume 
2015
N/A
2016
2017/3
2017
2018/3
2018
2018/12
2019
2019/12
Net sales  0 257,406 283,361 285,502 0  
Net sales growth  0.0% 0.0% 10.1% 0.8% -100.0%  
Gross profit  0.0 57,277 58,978 48,877 0.0  
Gross profit growth  0.0% 0.0% 3.0% -17.1% -100.0%  
Employees  0 190 220 208 0  
Employee growth %  0.0% 0.0% 15.8% -5.5% -100.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 222,667 271,051 287,680 0  
Balance sheet change%  0.0% 0.0% 21.7% 6.1% -100.0%  
Added value  0.0 39,355.0 37,960.0 26,406.0 0.0  
Added value %  0.0% 15.3% 13.4% 9.2% 0.0%  
Investments  0 38,256 256 2,455 -60,557  
Net sales trend  0.0 0.0 1.0 2.0 -1.0  
EBIT trend  0.0 1.0 2.0 3.0 0.0  

Profitability 
2015
N/A
2016
2017/3
2017
2018/3
2018
2018/12
2019
2019/12
EBITDA %  0.0% 15.3% 13.4% 10.2% 0.0%  
EBIT %  0.0% 12.8% 11.5% 7.4% 0.0%  
EBIT to gross profit (%)  0.0% 57.6% 55.4% 43.3% 0.0%  
Net Earnings %  0.0% 3.1% 8.2% 4.7% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 5.6% 10.1% 7.5% 0.0%  
Pre tax profit less extraordinaries %  0.0% 7.0% 12.0% 7.0% 0.0%  
ROA %  0.0% 19.7% 14.2% 7.5% 0.0%  
ROI %  0.0% 29.8% 19.7% 9.8% 0.0%  
ROE %  0.0% 20.2% 45.3% 19.3% 0.0%  

Solidity 
2015
N/A
2016
2017/3
2017
2018/3
2018
2018/12
2019
2019/12
Equity ratio %  0.0% 17.9% 23.3% 26.7% 0.0%  
Relative indebtedness %  0.0% 70.2% 72.9% 73.2% 0.0%  
Relative net indebtedness %  0.0% 69.7% 70.2% 68.1% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 264.8% 360.8% 423.2% 0.0%  
Gearing %  0.0% 264.3% 228.7% 179.8% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 49.0% 0.9% 0.6% 0.0%  

Liquidity 
2015
N/A
2016
2017/3
2017
2018/3
2018
2018/12
2019
2019/12
Quick Ratio  0.0 0.4 0.4 0.4 0.0  
Current Ratio  0.0 1.1 1.2 1.1 0.0  
Cash and cash equivalent  0.0 1,183.0 7,667.0 14,738.0 0.0  

Capital use efficiency 
2015
N/A
2016
2017/3
2017
2018/3
2018
2018/12
2019
2019/12
Trade debtors turnover (days)  0.0 55.2 75.9 46.6 0.0  
Trade creditors turnover (days)  0.0 675.6 551.2 733.4 0.0  
Current assets / Net sales %  0.0% 63.8% 73.6% 75.2% 0.0%  
Net working capital  0.0 18,083.0 27,580.0 21,443.0 0.0  
Net working capital %  0.0% 7.0% 9.7% 7.5% 0.0%  

Employee efficiency 
2015
N/A
2016
2017/3
2017
2018/3
2018
2018/12
2019
2019/12
Net sales / employee  0 1,355 1,288 1,373 0  
Added value / employee  0 207 173 127 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 207 173 140 0  
EBIT / employee  0 174 149 102 0  
Net earnings / employee  0 42 106 65 0